<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>Department of Pharmaceuticals | IndusDesk</title>
  <link>https://indusdesk.com/department-of-pharmaceuticals/insights/</link>
  <atom:link href="https://indusdesk.com/feed/department-of-pharmaceuticals.xml" rel="self" type="application/rss+xml"/>
  <description>Department of Pharmaceuticals: recent notices, each summarized and linked to the notice itself.</description>
  <language>en-us</language>
  <lastBuildDate>Tue, 10 Nov 2026 00:00:00 GMT</lastBuildDate>

  <item>
    <title>Medical devices PLI extended to FY 2035-36, fresh applications invited</title>
    <link>https://indusdesk.com/department-of-pharmaceuticals/insights/medical-devices-pli-extended-to-fy-2035-36-fresh-applications-invited/</link>
    <guid isPermaLink="false">https://indusdesk.com/insights/#2026-11-10-medical-devices-pli-extended-to-fy-2035-36-fresh-applications-invited</guid>
    <pubDate>Tue, 10 Nov 2026 00:00:00 GMT</pubDate>
    <category>Department of Pharmaceuticals</category>
    <description>Companies and LLPs can apply afresh in four segments, including critical components, for incentives of 3% to 10% of incremental sales over five years. In three segments, a Rs 50 crore minimum investment applies only below Rs 150 crore turnover.</description>
  </item>

</channel>
</rss>
